Vivani Medical (NASDAQ:VANI – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.
Vivani Medical Stock Down 0.9 %
Shares of NASDAQ:VANI opened at $1.09 on Friday. The firm has a fifty day simple moving average of $1.14 and a two-hundred day simple moving average of $1.21. Vivani Medical has a 52 week low of $1.03 and a 52 week high of $2.22. The stock has a market capitalization of $64.57 million, a P/E ratio of -2.42 and a beta of 3.20.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and issued a $4.00 price target on shares of Vivani Medical in a report on Thursday, March 13th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- How to Short a Stock in 5 Easy Steps
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- 3 REITs to Buy and Hold for the Long Term
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
